Korean Circulation Journal

The Korean Society of Cardiology (대한심장학회)
권호 표지
DOI QR코드

DOI QR Code

Pulmonary Alveolar Hemorrhage after Clopidogrel Use for ST Elevation Myocardial Infarction

  • Kim, Youngjoong (Division of Cardiology, Department of Internal Medicine, Konkuk University College of Medicine) ;
  • Lim, Joohan (Division of Hemato-Oncology, Department of Internal Medicine, Inha University College of Medicine) ;
  • Lim, Jonggu (Division of Cardiology, Department of Internal Medicine, Konkuk University College of Medicine) ;
  • Kim, Soohyun (Division of Cardiology, Department of Internal Medicine, Konkuk University College of Medicine) ;
  • Jung, Taeyoung (Division of Cardiology, Department of Internal Medicine, Konkuk University College of Medicine) ;
  • Choi, Woonggil (Division of Cardiology, Department of Internal Medicine, Konkuk University College of Medicine)
  • Published : 2013.07.30
⟨ Previous Next ⟩

Abstract

Combination treatment of antiplatelet drugs containing aspirin and clopidogrel reduces systemic ischemic events after percutaneous coronary intervention (PCI) in high risk patients. However, this combination treatment of antiplatelet drugs is associated with increased risk of nonfatal and fatal bleeding. Diffuse alveolar hemorrhage after PCI is a rare complication that has been mostly reported in association with glycoprotein IIb/IIIa inhibitors. We report the case of a 62-year-old man who presented with ST elevation myocardial infarction and suffered a diffuse alveolar hemorrhage after clopidogrel use following primary PCI.

Keywords

References

  1. Peters RJ, Mehta SR, Fox KA, et al. Effects of aspirin dose when used alone or in combination with clopidogrel in patients with acute coronary syndromes: observations from the Clopidogrel in Unstable angina to prevent Recurrent Events (CURE) study. Circulation 2003;108:1682-7. https://doi.org/10.1161/01.CIR.0000091201.39590.CB
  2. Mehta SR, Tanguay JF, Eikelboom JW, et al. Double-dose versus standard- dose clopidogrel and high-dose versus low-dose aspirin in individuals undergoing percutaneous coronary intervention for acute coronary syndromes (CURRENT-OASIS 7): a randomised factorial trial. Lancet 2010;376:1233-43. https://doi.org/10.1016/S0140-6736(10)61088-4
  3. Chae SC. Antiplatelet agents in high-risk patients with coronary artery disease. Korean Circ J 2004;34:23-7. https://doi.org/10.4070/kcj.2004.34.1.23
  4. Fox KA, Mehta SR, Peters R, et al. Benefits and risks of the combination of clopidogrel and aspirin in patients undergoing surgical revascularization for non-ST-elevation acute coronary syndrome: the Clopidogrel in Unstable angina to prevent Recurrent ischemic Events (CURE) Trial. Circulation 2004;110:1202-8. https://doi.org/10.1161/01.CIR.0000140675.85342.1B
  5. Hansen ML, Sørensen R, Clausen MT, et al. Risk of bleeding with single, dual, or triple therapy with warfarin, aspirin, and clopidogrel in patients with atrial fibrillation. Arch Intern Med 2010;170:1433-41.
  6. Payne DA, Hayes PD, Jones CI, Belham P, Naylor AR, Goodall AH. Combined therapy with clopidogrel and aspirin significantly increases the bleeding time through a synergistic antiplatelet action. J Vasc Surg 2002;35:1204-9. https://doi.org/10.1067/mva.2002.122027
  7. Kushner FG, Hand M, Smith SC Jr, et al. 2009 focused updates: ACC/ AHA guidelines for the management of patients with ST-elevation myocardial infarction (updating the 2004 guideline and 2007 focused update) and ACC/AHA/SCAI guidelines on percutaneous coronary intervention (updating the 2005 guideline and 2007 focused update) a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol 2009;54:2205-41. https://doi.org/10.1016/j.jacc.2009.10.015
  8. Eikelboom JW, Mehta SR, Anand SS, Xie C, Fox KA, Yusuf S. Adverse impact of bleeding on prognosis in patients with acute coronary syndromes. Circulation 2006;114:774-82. https://doi.org/10.1161/CIRCULATIONAHA.106.612812
  9. Ener RA, Bruno N, Dadourian D, et al. Alveolar hemorrhage associated with platelet glycoprotein IIb/IIIa receptor inhibitors. J Invasive Cardiol 2006;18:254-61.
  10. Kilaru PK, Schweiger MJ, Kozman HA, Weil TR. Diffuse alveolar hemorrhage after clopidogrel use. J Invasive Cardiol 2001;13:535-7.
  11. Ikeda M, Tanaka H, Sadamatsu K. Diffuse alveolar hemorrhage as a complication of dual antiplatelet therapy for acute coronary syndrome. Cardiovasc Revasc Med 2011;12:407-11. https://doi.org/10.1016/j.carrev.2011.03.003

Cited by

  1. Aspirin/clopidogrel : Pulmonary alveolar haemorrhage: case report vol.1471, pp.1, 2013, https://doi.org/10.1007/s40278-013-6093-z
  2. Clinical Features and Outcomes of Diffuse Alveolar Hemorrhage During Antithrombotic Therapy: A Retrospective Cohort Study vol.194, pp.3, 2013, https://doi.org/10.1007/s00408-016-9873-4
  3. Pulmonary alveolar hemorrhage mimicking a pneumopathy: a rare complication of dual antiplatelet therapy for ST elevation myocardial infarction vol.24, pp.None, 2016, https://doi.org/10.11604/pamj.2016.24.308.8828
  4. Diffuse Alveolar Hemorrhage in Patients Undergoing Neurointervention: A Case Report vol.6, pp.5, 2013, https://doi.org/10.5812/aapm.33979
  5. Heart-lung transplantation for refractory diffuse alveolar hemorrhage supported by prolonged extracorporeal membrane oxygenation after cardiogenic shock from ST segment elevation myocardial infarction vol.35, pp.8, 2013, https://doi.org/10.1177/0267659120915396
  6. Clopidogrel-Induced Interstitial Lung Disease: A Case Report vol.17, pp.None, 2013, https://doi.org/10.2147/tcrm.s319077
  7. Diffuse alveolar haemorrhage: a rare complication of clopidogrel use vol.14, pp.8, 2021, https://doi.org/10.1136/bcr-2021-244314